# Open Label Trial of Perifosine in Patients Currently Being Treated on Perifosine Trials in Solid Tumors or Multiple Myeloma

> **NCT00847366** · NA · COMPLETED · sponsor: **AEterna Zentaris** · enrollment: 10 (actual)

## Conditions studied

- Non Small Cell Lung Cancer
- Solid Tumors
- Metastatic Breast Cancer
- Sarcomas

## Interventions

- **DRUG:** Perifosine
- **DRUG:** Trastuzumab
- **DRUG:** Tamoxifen

## Key facts

- **NCT ID:** NCT00847366
- **Lead sponsor:** AEterna Zentaris
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-05
- **Primary completion:** 2012-12
- **Final completion:** 2012-12
- **Target enrollment:** 10 (ACTUAL)
- **Last updated:** 2018-03-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00847366

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00847366, "Open Label Trial of Perifosine in Patients Currently Being Treated on Perifosine Trials in Solid Tumors or Multiple Myeloma". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00847366. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*